Please see our full publication list here.
Select publications that are the most representative of our expertise and focus:
Adaptive Decision Making
- Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic. Med Decis Making. 2021 May;41(4):386-392. doi: 10.1177/0272989X21990371. Epub 2021 Jan 27. PubMed PMID: 33504258; PubMed Central PMCID: PMC8084913.
- Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study. PLoS Med. 2020 Apr;17(4):e1003077. doi: 10.1371/journal.pmed.1003077. eCollection 2020 Apr. PubMed PMID: 32243443; PubMed Central PMCID: PMC7122693.
- Identifying cost-effective dynamic policies to control epidemics. Stat Med. 2016 Dec 10;35(28):5189-5209. doi: 10.1002/sim.7047. Epub 2016 Jul 24. PubMed PMID: 27449759; PubMed Central PMCID: PMC5096998.
- Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics. Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9457-62. doi: 10.1073/pnas.1218770110. Epub 2013 May 20. PubMed PMID: 23690585; PubMed Central PMCID: PMC3677479.
Clinical and Public Health Informatics
- Forecasting Local Surges in COVID-19 Hospitalizations through Adaptive Decision Tree Classifiers. Med Decis Making. 2026 Feb 2;:272989X251408845. doi: 10.1177/0272989X251408845. [Epub ahead of print] PubMed PMID: 41626707.
- Personalizing the empiric treatment of gonorrhea using machine learning models. PLOS Digit Health. 2024 Aug;3(8):e0000549. doi: 10.1371/journal.pdig.0000549. eCollection 2024 Aug. PubMed PMID: 39141668; PubMed Central PMCID: PMC11324139.
- Generating simple classification rules to predict local surges in COVID-19 hospitalizations. Health Care Manag Sci. 2023 Jun;26(2):301-312. doi: 10.1007/s10729-023-09629-4. Epub 2023 Jan 24. PubMed PMID: 36692583; PubMed Central PMCID: PMC9872755.
- Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods. PLOS Digit Health. 2022;1(6). doi: 10.1371/journal.pdig.0000059. Epub 2022 Jun 30. PubMed PMID: 36177394; PubMed Central PMCID: PMC9518704.
Simulation and Mathematical Modeling
- The Impact of Rapid Drug Susceptibility Tests on Gonorrhea Burden and the Life Span of Antibiotic Treatments: A Modeling Study Among Men Who Have Sex With Men in the United States. Am J Epidemiol. 2024 Jan 8;193(1):17-25. doi: 10.1093/aje/kwad175. PubMed PMID: 37625444; PubMed Central PMCID: PMC10773484.
- Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLoS Comput Biol. 2022 Feb;18(2):e1009842. doi: 10.1371/journal.pcbi.1009842. eCollection 2022 Feb. PubMed PMID: 35139073; PubMed Central PMCID: PMC8863219.
Cost-Effectiveness Analysis (Methods and Applications)
- Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under Uncertainty. Med Decis Making. 2024 Oct;44(7):770-786. doi: 10.1177/0272989X241262343. Epub 2024 Jul 26. PubMed PMID: 39056310; PubMed Central PMCID: PMC12181631.
- How Many Monte Carlo Samples Are Needed for Probabilistic Cost-Effectiveness Analyses?. Value Health. 2024 Nov;27(11):1553-1563. doi: 10.1016/j.jval.2024.06.016. Epub 2024 Jul 6. PubMed PMID: 38977192.
- Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis. PLoS Med. 2024 Jul;21(7):e1004424. doi: 10.1371/journal.pmed.1004424. eCollection 2024 Jul. PubMed PMID: 38976754; PubMed Central PMCID: PMC11262662.
- Cost-Effectiveness and Long-Term Savings of the Bright Bodies Intervention for Childhood Obesity. Value Health. 2023 Aug;26(8):1183-1191. doi: 10.1016/j.jval.2023.03.006. Epub 2023 Mar 24. PubMed PMID: 36967028; PubMed Central PMCID: PMC10518029.
- Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Lancet Glob Health. 2020 Sep;8(9):e1223-e1233. doi: 10.1016/S2214-109X(20)30227-8. PubMed PMID: 32827484; PubMed Central PMCID: PMC7549318.
- Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study. Med Decis Making. 2019 Jul;39(5):553-567. doi: 10.1177/0272989X19859899. Epub 2019 Jul 3. PubMed PMID: 31268405; PubMed Central PMCID: PMC6786941.
- The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLoS Med. 2018 Jan;15(1):e1002495. doi: 10.1371/journal.pmed.1002495. eCollection 2018 Jan. PubMed PMID: 29364884; PubMed Central PMCID: PMC5783340.